{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:18:19Z","timestamp":1768915099158,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.farma.2022.12.007","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T23:39:57Z","timestamp":1682120397000},"page":"T20-T25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["[Art\u00edculo traducido] Prevalencia de reacciones adversas a medicamentos asociadas a visitas al servicio de urgencias y factores de riesgo de hospitalizaci\u00f3n"],"prefix":"10.1016","volume":"47","author":[{"given":"David","family":"Brandariz-N\u00fa\u00f1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Ferreiro-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Suanzes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Margusino-Frami\u00f1\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"de la C\u00e1mara-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Fandi\u00f1o-Orgueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel","family":"Mart\u00edn-Herranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 10","key":"10.1016\/j.farma.2022.12.007_bb0005","first-page":"S36","article-title":"Adverse drug reactions across the age continuum: epidemiology, diagnostic challenges, prevention, and treatments","volume":"58","author":"Rieder","year":"2018","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.farma.2022.12.007_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40360-018-0207-4","article-title":"Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study","volume":"19","author":"Lombardi","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"issue":"6","key":"10.1016\/j.farma.2022.12.007_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1258\/jrsm.2010.100113","article-title":"Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009","volume":"103","author":"Wu","year":"2010","journal-title":"J R Soc Med"},{"issue":"7","key":"10.1016\/j.farma.2022.12.007_bb0020","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1592\/phco.22.11.915.33630","article-title":"Drug-related visits to the emergency department: how big is the problem?","volume":"22","author":"Patel","year":"2002","journal-title":"Pharmacotherapy."},{"issue":"1","key":"10.1016\/j.farma.2022.12.007_bb0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/emermed-2012-201945","article-title":"Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study","volume":"31","author":"Ahern","year":"2014","journal-title":"Emerg Med J"},{"issue":"4","key":"10.1016\/j.farma.2022.12.007_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00228-016-2170-6","article-title":"Hospitalizations due to preventable adverse reactions-a systematic review","volume":"73","author":"Patel","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.farma.2022.12.007_bb0035","series-title":"To Err is Human: Building a Safer Health System","article-title":"Committee on Quality of Health Care in America","author":"Institute of Medicine (US)","year":"2000"},{"issue":"4","key":"10.1016\/j.farma.2022.12.007_bb0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","author":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.farma.2022.12.007_bb0045","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/qhc.12.4.280","article-title":"Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study","volume":"12","author":"Howard","year":"2003","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.farma.2022.12.007_bb0050","first-page":"505","article-title":"Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization","volume":"6","author":"Perrone","year":"2014","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.farma.2022.12.007_bb0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fphar.2020.00412","article-title":"Italian emergency department visits and hospitalizations for outpatients' adverse drug events: 12-year active pharmacovigilance surveillance (The MEREAFaPS study)","volume":"11","author":"Lombardi","year":"2020","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.farma.2022.12.007_bb0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00228-015-1974-0","article-title":"Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features","volume":"72","author":"Pedr\u00f3s","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"issue":"9237","key":"10.1016\/j.farma.2022.12.007_bb0065","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet."},{"issue":"10","key":"10.1016\/j.farma.2022.12.007_bb0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.medcli.2016.06.012","article-title":"Evaluaci\u00f3n de la causalidad en las comunicaciones de reacciones adversas a medicamentos. Algoritmo del Sistema Espa\u00f1ol de Farmacovigilancia","volume":"147","author":"Aguirre","year":"2016","journal-title":"Med Clin"},{"issue":"5","key":"10.1016\/j.farma.2022.12.007_bb0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.farma.2022.12.007_bb0080","author":"Instituto para el Uso Seguro de los Medicamentos"},{"key":"10.1016\/j.farma.2022.12.007_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2042098619852552","article-title":"Understanding adverse drug-related emergency department visits: development of a conceptual model through a systematic review","volume":"10","author":"Jatau","year":"2019","journal-title":"Ther Adv Drug Saf"},{"issue":"5","key":"10.1016\/j.farma.2022.12.007_bb0090","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40264-015-0281-0","article-title":"Epidemiology of adverse drug reactions in Europe: a review of recent observational studies","volume":"38","author":"Bouvy","year":"2015","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.farma.2022.12.007_bb0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.farma.2010.01.009","article-title":"Incidencia de resultados negativos de medicaci\u00f3n en un servicio de urgencias hospitalario y factores asociados","volume":"34","author":"Ramos-Linares","year":"2010","journal-title":"Farm Hosp"},{"issue":"5","key":"10.1016\/j.farma.2022.12.007_bb0100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11096-013-9795-7","article-title":"Drug-related visits to the emergency department in a Spanish university hospital","volume":"35","author":"Castro","year":"2013","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.farma.2022.12.007_bb0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/emermed-2012-201945","article-title":"Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish university hospital: a cross-sectional study","volume":"31","author":"Ahern","year":"2014","journal-title":"Emerg Med J"},{"issue":"7","key":"10.1016\/j.farma.2022.12.007_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14224","article-title":"Impact of medication characteristics and adverse drug events on hospital admission after an emergency department visit: Prospective cohort study","volume":"75","author":"Lohan","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.farma.2022.12.007_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.annemergmed.2009.10.008","article-title":"Do emergency physicians attribute drug-related emergency department visits to medication-related problems?","volume":"55","author":"Hohl Corinne","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.farma.2022.12.007_bb0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/emermed-2011-200482","article-title":"Assessment of adverse drug event recognition by emergency physicians in a French teaching hospital","volume":"30","author":"Roulet","year":"2013","journal-title":"Emerg Med J"},{"issue":"2","key":"10.1016\/j.farma.2022.12.007_bb0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s41999-021-00580-7","article-title":"Geriatric characteristics and the risk of drug-related hospital admissions in older Emergency Department patients","volume":"13","author":"Luttikhuis","year":"2022","journal-title":"Eur Geriatr Med"},{"issue":"4","key":"10.1016\/j.farma.2022.12.007_bb0130","first-page":"176","article-title":"Prevalence of adverse drug events in emergency departments. FARM-URG multi-center project","volume":"45","author":"Ruiz-Ramos","year":"2021","journal-title":"Farm Hosp"},{"issue":"9","key":"10.1016\/j.farma.2022.12.007_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272743","article-title":"Adverse drug events leading to emergency department visits: A multicenter observational study in Korea","volume":"17","author":"Kang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.farma.2022.12.007_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s43587-021-00045-3","article-title":"Emerging approaches to polypharmacy among older adults","volume":"1","author":"Mehta","year":"2021","journal-title":"Nat Aging"},{"issue":"2","key":"10.1016\/j.farma.2022.12.007_bb0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hfc.2013.12.001","article-title":"Comorbidities and polypharmacy","volume":"10","author":"Von Lueder","year":"2014","journal-title":"Heart Fail Clin"},{"issue":"11","key":"10.1016\/j.farma.2022.12.007_bb0150","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1111\/bcp.14851","article-title":"Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database","volume":"87","author":"Montastruc","year":"2021","journal-title":"Br J Clin Pharmacol"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634322000162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634322000162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:17:20Z","timestamp":1761106640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634322000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1130634322000162"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2022.12.007","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Art\u00edculo traducido] Prevalencia de reacciones adversas a medicamentos asociadas a visitas al servicio de urgencias y factores de riesgo de hospitalizaci\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2022.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2022.10.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}